LivaNova (LIVN) Current Assets (2015 - 2026)
LivaNova (LIVN) reported Current Assets of $1.0 billion for Q1 2026, down 13.4% on a YoY basis from $1.2 billion in Q1 2025, and down 7.93% sequentially from $1.1 billion in Q4 2025.
LivaNova (LIVN) Current Assets (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Current Assets data on file, last reported at $1.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 13.4% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (down 13.4% YoY), and the FY2025 full-year result was $1.1 billion, down 2.27% from the prior year.
- Current Assets retreated to $1.0 billion in Q1 2026, from $1.1 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.2 billion in Q1 2025 to a low of $771.9 million in Q2 2022.
- A 5-year average of $991.9 million and a median of $1.0 billion in 2026 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 31.7% in 2022 and retreated 13.4% in 2026, its largest moves.
- Tracing LIVN's Current Assets over 5 years: stood at $886.1 million in 2022, then increased by 11.51% to $988.2 million in 2023, then rose by 14.07% to $1.1 billion in 2024, then slipped by 2.27% to $1.1 billion in 2025, then dropped by 7.93% to $1.0 billion in 2026.
- Business Quant data shows LIVN's Current Assets at $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.05 Bn |
| Mar 31, 2024 | 1.04 Bn |
| Dec 31, 2023 | 988.16 Mn |
| Sep 30, 2023 | 953.87 Mn |
| Jun 30, 2023 | 941.84 Mn |
| Mar 31, 2023 | 903.02 Mn |
| Dec 31, 2022 | 886.14 Mn |
| Sep 30, 2022 | 851.22 Mn |
| Jun 30, 2022 | 771.93 Mn |
| Mar 31, 2022 | 809.62 Mn |
| Dec 31, 2021 | 679.18 Mn |
| Sep 30, 2021 | 646.36 Mn |
| Jun 30, 2021 | 809.10 Mn |